According to uniQure's latest financial reports the company's current EPS (TTM) is -$3.94. In 2022 the company made an earnings per share (EPS) of -$2.71 a decrease over its 2021 EPS that were of $7.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.94 | 45.39% |
2022 | -$2.71 | -137.9% |
2021 | $7.15 | -354.45% |
2020 | -$2.81 | -9.94% |
2019 | -$3.12 | 33.33% |
2018 | -$2.34 | -20.41% |
2017 | -$2.94 | 0.34% |
2016 | -$2.93 | -19.32% |
2015 | -$3.63 | 20.49% |
2014 | -$3.01 | 46.09% |
2013 | -$2.06 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Amgen AMGN | $14.15 | -459.14% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -180.72% | ๐ซ๐ท France |
Sangamo Therapeutics
SGMO | -$1.44 | -63.45% | ๐บ๐ธ USA |
bluebird bio
BLUE | -$1.02 | -74.11% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $0.78 | -119.76% | ๐บ๐ธ USA |
Avidity Biosciences RNA | -$3.10 | -21.32% | ๐บ๐ธ USA |